Eculizumab in atypical hemolytic uremic syndrome: Long-term clinical course and histological findings

Pediatric Nephrology

Volumn 26, Issue 11, 2011, Pages 2085-2088

  Tschumi, Sibylle ^a   Gugger, Mathias ^a   Bucher, Barbara S ^a   Riedl, Magdalena ^b   Simonetti, Giacomo D ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Atypical hemolytic uremic syndrome; Children; Complement; Eculizumab; Factor H

Indexed keywords

ANTIHYPERTENSIVE AGENT; COMPLEMENT; COMPLEMENT FACTOR H; ECULIZUMAB; MENINGITIS VACCINE;

ALLERGY; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATYPICAL HEMOLYTIC UREMIC SYNDROME; BLOOD VOLUME; CASE REPORT; CHILD; COMPLEMENT INHIBITION; DISEASE COURSE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; LONG TERM CARE; MENINGOCOCCOSIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; QUALITY OF LIFE; RELAPSE; RHINITIS; RISK FACTOR; SCHOOL CHILD; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CHILD; COMPLEMENT FACTOR H; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MUTATION; PLASMA EXCHANGE;

EID: 83155172386     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1989-4     Document Type: Article

References (15)

1. Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R (1955) hemolytic-uremic syndrome: Bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr 85:905-909
2. Kavanagh D, Goodship T (2010) Genetics and complement in atypical hus. Pediatr Nephrol 25:2431-2442
3. Loirat C, Noris M, Fremeaux-Bacchi V (2008) Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol 23:1957-1972
4. Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C (2007) Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 18:2392-2400 (Pubitemid 47203855)
5. Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB (2009) Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 24:687-696
6. Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, Mitchell LD, Cohen DR, Gregory WM, Hillmen P (2011) Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: Sustained efficacy and improved survival. Blood 117:6786-6792
7. Al-Akash SI, Almond PS, Savell VH Jr, Gharaybeh SI, Hogue C (2011) Eculizumab induces long-term remission in recurrent posttransplant hus associated with c3 gene mutation. Pediatr Nephrol 26:613-619
8. Gruppo RA, Rother RP (2009) Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med 360:544-546
9. Mache CJ, Acham-Roschitz B, Fremeaux-Bacchi V, Kirschfink M, Zipfel PF, Roedl S, Vester U, Ring E (2009) Complement inhibitor eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1312-1316
10. Nester C, Stewart Z, Myers D, Jetton J, Nair R, Reed A, Thomas C, Smith R, Brophy P (2011) Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 6:1488-1494
11. Nurnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, Baba HA, Kribben A, Zimmerhackl LB, Janecke AR, Nagel M, Kirschfink M (2009) Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med 360:542-544
12. Lapeyraque AL, Fremeaux-Bacchi V, Robitaille P (2011) Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome. Pediatr Nephrol 26:621-624
13. Weitz M, Amon O, Bassler D, Koenigsrainer A, Nadalin S (2011) Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr Nephrol 26:1325-1329
14. Zimmerhackl LB, Hofer J, Cortina G, Mark W, Würzner R, Jungraithmayr TC, Khursigara G, Kliche KO, Radauer W (2010) Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med 362(18):1746-1748
15. Bouts A, Monnens L, Davin JC, Struijk G, Spanjaard L (2011) Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy. Pediatr Nephrol. doi:10.007/s00477-011-1929-3